ChemicalBook > Product Catalog >API >Hormones and the Endocrine System >Others >Octreotide

Octreotide

Octreotide Structure
CAS No.
79517-01-4
Chemical Name:
Octreotide
Synonyms
SANDOSTATIN;(D-Phe)-Cys-Phe-(D-Trp)-Lys-Thr-Cys-Thr-ol (Disulfide bond 2-7);Ktreotide;800016R-1;OCTREOTIDE;SMS-201-995;SMS 201-995ac;Octreotide/OTC;Sandostatin LAR;Octreotide xAcetate
CBNumber:
CB0279552
Molecular Formula:
C51H70N10O12S2
Molecular Weight:
1079.3
MOL File:
79517-01-4.mol
MSDS File:
SDS
Modify Date:
2024/7/4 21:45:01

Octreotide Properties

Melting point 153-156°C
alpha D20 -42° (c = 0.5 in 95% acetic acid)
storage temp. Inert atmosphere,Store in freezer, under -20°C
solubility H2O: soluble
form Solid
color White to Off-White
Stability Hygroscopic
InChIKey XQEJFZYLWPSJOV-XJQYZYIXSA-N
CAS DataBase Reference 79517-01-4

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H315-H319
Precautionary statements  P305+P351+P338
WGK Germany  3
HS Code  2937190000
Toxicity TDLo scu-man: 2587 mg/kg:GIT,LVR LANCAO348,1668,1996

Octreotide price More Price(1)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) PHR1880 Octreotide Acetate Pharmaceutical Secondary Standard; Certified Reference Material 79517-01-4 10MG ₹30299.18 2022-06-14 Buy
Product number Packaging Price Buy
PHR1880 10MG ₹30299.18 Buy

Octreotide Chemical Properties,Uses,Production

Chemical Properties

Colourless to off-white lyophilised solid

Uses

Octreotide acetate USP (Sandostatin) is used to treat Mestastatic carcinoid tumors; vasoactive intestinal peptide-secretory tumors.

Indications

Octreotide (Sandostatin) is a synthetic somatostatin analogue. It is used in a variety of situations and must be given subcutaneously or intravenously. Most commonly, it is used as a continuous intravenous infusion in patients hospitalized with bleeding varices, because it decreases splanchnic circulation and therefore reduces portal pressures.A long-acting depot form is approved for the suppression of severe diarrhea and flushing associated with malignant carcinoid syndrome and for the treatment of the profuse watery diarrhea associated with vasoactive intestinal peptide tumor.

General Description

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

Safety Profile

A poison by subcutaneous andintravenous routes. Human systemic effects: changes instructure or function of endocrine pancreas, liver functiontests impaired. When heated to decomposition it emitstoxic vapors of NOx and SOx

Octreotide Preparation Products And Raw materials

Global( 302)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Jigs Chemical ltd +919099003427 Gujarat, India 239 58 Inquiry
USV Pvt Ltd +91-2267861111 +91-2225564048 Maharashtra, India 36 58 Inquiry
Piramal Pharma Solutions +919892735994 Maharashtra, India 48 58 Inquiry
Sun Pharmaceutical Industries Ltd +91-2242244224 +91-2243244324 Maharashtra, India 108 58 Inquiry
Ralington Pharma +91-7948911722 +91-9687771722 Gujarat, India 1350 58 Inquiry
Mylan Laboratories Ltd +91-4023550543 +91-4030866666 Telangana, India 150 58 Inquiry
OCEAN TRADING CORPORATION +91(22) 24921669 New Delhi, India 6211 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry

Related articles

SMS-201-995 [r-(r*,r*)]-d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-[2-hydroxy-1-(hydroxy-methyl)propyl]-cysteinamide cyclic(2->7)-disulfide OCTREOTIDE OCTREOTIDE (SMS 201-995), ACETATE cyclic(2-7)-disulfide,(r-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl) Octreotide (D-Phe5,Cys6·11,D-Trp8,L-Threoninol12)-SoMatostatin-14 (5-12), SMS-201-995 D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxyMethyl)propyl]- D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Threoninol (Disulfide bridge Cys2-Cys7) (D-Phe5,Cys6·11,D-Trp8,L-Threoninol12)-SoMatostatin-14 (5-12), SMS 201-995 Octreotide, (D-Phe5,Cys611,D-Trp8,L-Threoninol12)- Somatostatin-14 (5-12) (D-PHE5,CYS6,11,D-TRP8,L-THREONINOL12)-SOMATOSTATIN-14 (5-12) D-PHE-CYS-PHE-D-TRP-LYS-THR-CYS-THR-ALCOHOL D-PHE-CYS-PHE-D-TRP-LYS-THR-CYS-THREONINOL DPHE-CYS-PHE-DTRP-LYS-THR-CYS-THR-OL D-PHE-CYS-PHE-D-TRP-LYS-THR-CYS-THR-OL [DISULFIDE BRIDGE: CYS2-CYS7] FCFWKTCT-OL (DISULFIDE BRIDGE: 2-7) H-D-PHE-CYS-PHE-D-TRP-LYS-THR-CYS-L-THREONINOL H-D-PHE-CYS-PHE-D-TRP-LYS-THR-CYS-L-THREONINOL, (DISULFIDE BOND) H-D-PHE-CYS-PHE-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-cysteinamid r*))-(racetate(salt) L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2-7)-disulfide, acetate (salt) Sandostatin LAR SMS 201-995ac D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide Cyclic (2-7)-Disulfide Acetate Octreotide (SMS 201-995) M.W. 1019.24 C49H66N10O10S2 acetic acid,10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide 79517-01-4Octreotide Acetate Octreotide acetate,SMS 201995, >99% Octreotide acetate (Synonyms: SMS 201-995 (acetate)) Octreotide xAcetate Octreotide acetate (SMS 201-995 (acetate)) SMS 201-995 (acetate) Octreotide acetate,SMS 201995 Octreotide Acetate (4.37 mg) Octreotide?Acetate impurity Octreotide acetate salt Octreotide USP/EP/BP Octreotide Acetate (COLD SHIPMENT REQUIRED) (1477604) SANDOSTATIN (D-Phe)-Cys-Phe-(D-Trp)-Lys-Thr-Cys-Thr-ol (Disulfide bond 2-7) Octreotide/OTC Ktreotide 800016R-1 Octreotide Acetate free base 79517-01-4 C49H66N10O10S2C2H4O2 C49H66N10O10S2 C51H70N10O12S2 C49H66N10O10S2xCH3COOH peptide Somatostatin receptor Intermediates & Fine Chemicals Peptides Pharmaceuticals Amino Acid Derivatives